249 related articles for article (PubMed ID: 38293612)
1. Research Progress of SN38 Drug Delivery System in Cancer Treatment.
Qi QR; Tian H; Yue BS; Zhai BT; Zhao F
Int J Nanomedicine; 2024; 19():945-964. PubMed ID: 38293612
[TBL] [Abstract][Full Text] [Related]
2. Advances in delivery of Irinotecan (CPT-11) active metabolite 7-ethyl-10-hydroxycamptothecin.
Si J; Zhao X; Gao S; Huang D; Sui M
Int J Pharm; 2019 Sep; 568():118499. PubMed ID: 31299338
[TBL] [Abstract][Full Text] [Related]
3. A nanotherapeutic strategy to overcome chemoresistance to irinotecan/7-ethyl-10-hydroxy-camptothecin in colorectal cancer.
Huang Q; Liu X; Wang H; Liu X; Zhang Q; Li K; Chen Y; Zhu Q; Shen Y; Sui M
Acta Biomater; 2022 Jan; 137():262-275. PubMed ID: 34718178
[TBL] [Abstract][Full Text] [Related]
4. Redox responsive 7-ethyl-10-hydroxycamptothecin (SN38) lysophospholipid conjugate: synthesis, assembly and anticancer evaluation.
He W; Du Y; Wang T; Wang J; Cheng L; Li X
Int J Pharm; 2021 Sep; 606():120856. PubMed ID: 34229071
[TBL] [Abstract][Full Text] [Related]
5. Prodrug and nanomedicine approaches for the delivery of the camptothecin analogue SN38.
Bala V; Rao S; Boyd BJ; Prestidge CA
J Control Release; 2013 Nov; 172(1):48-61. PubMed ID: 23928356
[TBL] [Abstract][Full Text] [Related]
6. SN38 polymeric nanoparticles: in vitro cytotoxicity and in vivo antitumor efficacy in xenograft balb/c model with breast cancer versus irinotecan.
Sepehri N; Rouhani H; Tavassolian F; Montazeri H; Khoshayand MR; Ghahremani MH; Ostad SN; Atyabi F; Dinarvand R
Int J Pharm; 2014 Aug; 471(1-2):485-97. PubMed ID: 24879937
[TBL] [Abstract][Full Text] [Related]
7. Novel SN38 derivative-based liposome as anticancer prodrug: an in vitro and in vivo study.
Wu C; Zhang Y; Yang D; Zhang J; Ma J; Cheng D; Chen J; Deng L
Int J Nanomedicine; 2019; 14():75-85. PubMed ID: 30587986
[TBL] [Abstract][Full Text] [Related]
8. Enhancing oral delivery and anticancer efficacy of 7-ethyl-10-hydroxycamptothecin through self-assembled micelles of deoxycholic acid grafted N'-nonyl-trimethyl chitosan.
Huang J; Tang X; Yang Z; Chen J; Wang K; Shi C; Liu Z; Wu M; Du Q
Colloids Surf B Biointerfaces; 2024 Feb; 234():113736. PubMed ID: 38215603
[TBL] [Abstract][Full Text] [Related]
9. Novel lipophilic SN38 prodrug forming stable liposomes for colorectal carcinoma therapy.
Xing J; Zhang X; Wang Z; Zhang H; Chen P; Zhou G; Sun C; Gu N; Ji M
Int J Nanomedicine; 2019; 14():5201-5213. PubMed ID: 31371956
[No Abstract] [Full Text] [Related]
10. Lipid nanoparticles loaded with 7-ethyl-10-hydroxycamptothecin-phospholipid complex: in vitro and in vivo studies.
Liu H; Lu H; Liao L; Zhang X; Gong T; Zhang Z
Drug Deliv; 2015; 22(6):701-9. PubMed ID: 24625262
[TBL] [Abstract][Full Text] [Related]
11. SN38-loaded <100 nm targeted liposomes for improving poor solubility and minimizing burst release and toxicity: in vitro and in vivo study.
Fang YP; Chuang CH; Wu YJ; Lin HC; Lu YC
Int J Nanomedicine; 2018; 13():2789-2802. PubMed ID: 29785106
[TBL] [Abstract][Full Text] [Related]
12. Enhanced Intratumoral Delivery of SN38 as a Tocopherol Oxyacetate Prodrug Using Nanoparticles in a Neuroblastoma Xenograft Model.
Nguyen F; Alferiev I; Guan P; Guerrero DT; Kolla V; Moorthy GS; Chorny M; Brodeur GM
Clin Cancer Res; 2018 Jun; 24(11):2585-2593. PubMed ID: 29514842
[No Abstract] [Full Text] [Related]
13. Dual 7-ethyl-10-hydroxycamptothecin conjugated phospholipid prodrug assembled liposomes with in vitro anticancer effects.
Du Y; Zhang W; He R; Ismail M; Ling L; Yao C; Fu Z; Li X
Bioorg Med Chem; 2017 Jun; 25(12):3247-3258. PubMed ID: 28465086
[TBL] [Abstract][Full Text] [Related]
14. Actively targeted delivery of SN38 by ultrafine iron oxide nanoparticle for treating pancreatic cancer.
Xue T; Xu P; Padelford J; Xue X; Wu AY; Li Y; Wang L
Invest New Drugs; 2022 Jun; 40(3):546-555. PubMed ID: 35290548
[TBL] [Abstract][Full Text] [Related]
15. Polydopamine Nanoparticles Camouflaged by Stem Cell Membranes for Synergistic Chemo-Photothermal Therapy of Malignant Bone Tumors.
Zhang M; Zhang F; Liu T; Shao P; Duan L; Yan J; Mu X; Jiang J
Int J Nanomedicine; 2020; 15():10183-10197. PubMed ID: 33363374
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and biological evaluation of novel SN38-glucose conjugate for colorectal cancer treatment.
Zhang R; Luo Y; Du C; Wu L; Wang Y; Chen Y; Li S; Jiang X; Xie Y
Bioorg Med Chem Lett; 2023 Feb; 81():129128. PubMed ID: 36639036
[TBL] [Abstract][Full Text] [Related]
17. Comparison of two self-assembled macromolecular prodrug micelles with different conjugate positions of SN38 for enhancing antitumor activity.
Liu Y; Piao H; Gao Y; Xu C; Tian Y; Wang L; Liu J; Tang B; Zou M; Cheng G
Int J Nanomedicine; 2015; 10():2295-311. PubMed ID: 25848251
[TBL] [Abstract][Full Text] [Related]
18. Structural Modification Endows Small-Molecular SN38 Derivatives with Multifaceted Functions.
Dai Y; Qian M; Li Y
Molecules; 2023 Jun; 28(13):. PubMed ID: 37446591
[TBL] [Abstract][Full Text] [Related]
19. Functionalized Nanoparticles Efficiently Enhancing the Targeted Delivery, Tumor Penetration, and Anticancer Activity of 7-Ethyl-10-Hydroxycamptothecin.
Liu X; Si J; Zhang Q; Huang Q; Gu D; Yang H; Chen X; Shen Y; Sui M
Adv Healthc Mater; 2018 Apr; 7(7):e1701140. PubMed ID: 29334179
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary delivery of liposomes co-loaded with SN38 prodrug and curcumin for the treatment of lung cancer.
Gao C; Zhang L; Xu M; Luo Y; Wang B; Kuang M; Liu X; Sun M; Guo Y; Teng L; Wang C; Zhang Y; Xie J
Eur J Pharm Biopharm; 2022 Oct; 179():156-165. PubMed ID: 36064084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
